INFOGRAPHIC
North American CDMO Landscape 2024
Exclusive new infographic summarises the main CDMO players operating facilities in North America.
Released ahead of CDMO Live 2024, this infographic summarises the main players with facilities in North America who develop and manufacture Active Pharmaceutical Ingredients, Biologics and Cell & Gene Therapies.
The United States accounts for nearly half of the global pharmaceutical revenues and is the world leader in contract development and manufacturing.
The contract manufacturing market in the United States is expected to reach $68.32 Billion USD by 2029, followed by China, India and Germany. Canada is also a significant market for CDMOs, expected to reach $7.88 Billion.
Despite the size of the North American market, it’s notable that growth forecasts are more modest over the 2023-2028 period than some other markets. The United States is forecast for +4.74% CAGR and Canada for 6.79% CAGR, compared to the higher levels of growth the CDMO market is expected to see from India (+11.34% CAGR) or China (+9.63% CAGR). Source: Mordor Intelligence
North American CDMO Landscape infographic
Download a free high resolution infographic by filling out the short form.
Who are we missing?
While every effort has been made to capture all contract manufacturers in the infographic, we are not yet comprehensive.
- Add your company by completing this short form so we can verify your inclusion
About CDMO Live
CDMO Live is the ultimate online partnering event for bio/pharma outsourcing. Join this exclusive online event on 13th June 2024 to discover the latest trends and best practices in contract manufacturing, and connect with leading partners who can accelerate and de-risk your small molecule and biologic projects.
Download the high resolution infographic
Latest CDMO News
